Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Sharp Therapeutics Logo
Sharp Therapeutics Growth Score
78
CB Rank
28132
Heat Score
67
Sharp Therapeutics is engaged in the development of biosensors for cellular biology research and high-throughput screening.
Founded
obfuscation
PublicPost-IPO Debt Pittsburgh, Pennsylvania, United States1-10 sharptx.com/
Biotechnology
Life Science
Medical Device
Overview

Sharp Therapeutics
Total Funding
obfuscation
Growth Score
78
Heat Score
67

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score78
-18 pts
in past quarter
Heat Score 67
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Sharp Therapeutics

CB Rank
28132
Sharp Therapeutics is engaged in the development of biosensors for cellular biology research and high-throughput screening.
Founded
obfuscation
PublicPost-IPO Debt Pittsburgh, Pennsylvania, United States1-10 sharptx.com/
Biotechnology
Life Science
Medical Device

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Sharp Edge Labs, Inc
Also Known As Sharp Edge Labs Inc.
Operating Status Active
Stock Symbol  CVE:SHRX
Company Type For Profit
Founders  Alan Waggoner, Marcel Bruchez
About the Company

Sharp Edge Labs, Inc. engages in developing biosensors for cellular biology research and high-throughput screening. The company’s products include targeted biosensors to the cellular biology research community. It offers its products based on the fluorogenic activating proteins that provide a detection method for cellular changes, which is

amendable to high-throughput screening and follow-up.

The company was incorporated in 2011 and is based in Pittsburgh, Pennsylvania.

Phone Number (412)475-9733
Predictions & Insights

Growth Insight

See this Growth Insight
Sharp Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Disco™ Discovery Platform
A platform combining laboratory automation, molecular-physics, and mathematical modeling to discover small molecules that correct protein defects in hereditary disorders.
CoreX™ Biology Technologies
A suite of sensitive assays that mimic disease states to discover compounds correcting genetic mutations through various mechanisms.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 9
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 9
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt
obfuscation
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
4
obfuscation
STX PARTNERSPost-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
STX PARTNERS Logo
STX PARTNERS
Yes
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
—
STX PARTNERS Logo
STX PARTNERS
Yes
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
—
STX PARTNERS Logo
STX PARTNERS
Yes
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
—
STX PARTNERS Logo
STX PARTNERS
Yes
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
—
STX PARTNERS Logo
STX PARTNERS
Yes
Post-IPO Debt - Sharp Therapeutics Logo
Post-IPO Debt - Sharp Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 19

Employee Profiles

News

News and Press

News•May 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 10, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

562

IT Spend

$90.4KThis year, Sharp Therapeutics is projected to spend $90.4K on IT, according to Aberdeen.

Active Website Tech Count

18Sharp Therapeutics is actively using 18 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Apple Mobile Web Clips Icon, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Sharp Therapeutics's headquarters? Sharp Therapeutics is located in Pittsburgh, Pennsylvania, United States.Who invested in Sharp Therapeutics? Sharp Therapeutics has 5 investors including STX PARTNERS and  Brooks Family Office.When was the last funding round for Sharp Therapeutics? Sharp Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Sharp Therapeutics's competitors? Alternatives and possible competitors to Sharp Therapeutics may include Insilico Medicine, Generate Biomedicines, and  Cradle.How much funding has Sharp Therapeutics raised to date? Sharp Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|